法定代表人： 于国权 主管会计工作负责人： 马长庆 会计机构负责人（会计主管人员）： 马琳 汇总表第 1 页 江苏长青农化股份有限公司 2023 年半年度 非经营性资金占用及其他关联资金往来情况汇总表 单位：万元 | 非经营性资金占用 | | 占用方与上 | 上市公司核算 | 年期初往 2023 | 年半年度往 2023 | 年半年度 2023 | 年半年 2023 | 年期末往 2023 | 占用形成原 | 占用性质 | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | | 资金占用方名称 | 市公司的关 联关系 | 的会计科目 | 来资金余额 | 来累计发生金额 （不含利息） | 往来资金的利 息(如有) | 度偿还累计 发生金额 | 来资金余额 | 因 | | | 控股股东、实际控制 | | | | | | | | | | 非经营性占用 | | 人及其附属企业 | | | | | | | | | | 非经营性占用 | | 小计 | | - - | - | | | | | | - | - | | 前控股股东、实际控 ...

江苏长青农化股份有限公司独立董事 关于公司第八届董事会第七次会议相关事项的独立意见 （此页无正文，为江苏长青农化股份有限公司独立董事关于公司第八届董事会第 七次会议相关事项的独立意见签字页） 根据《关于在上市公司建立独立董事制度的指导意见》、《上市公司自律监 管指引第1号—主板上市公司规范运作》及《公司独立董事工作制度》等相关规 定，作为江苏长青农化股份有限公司（下称"公司"）独立董事，现就公司第八 届董事会第七次会议相关事项发表如下独立意见： 龚新海____________ 李钟华____________ 一、对公司关联方资金占用和对外担保情况的专项说明和独立意见 根据中国证监会《上市公司监管指引第8号—上市公司资金往来、对外担保 的监管要求》及《上市公司章程指引（2022年修订）》第42条和第78条等的规定 和要求，作为公司的独立董事，我们对公司报告期内（2023年1月1日至2023年6 月30日）控股股东及关联方占用资金和对外担保情况进行了认真的了解和核查， 现发表如下独立意见： （二）公司严格执行《上市公司监管指引第8号—上市公司资金往来、对外 担保的监管要求》，报告期内公司不存在为控股股东及其他关联 ...

股票代码：002391 股票简称：长青股份 公告编号：2023-015 江苏长青农化股份有限公司（以下简称"公司"）第八届监事会第七次会议于 2023 年 8 月 14 日在公司会议室以现场方式召开，会议通知于 2023 年 8 月 1 日 以通讯方式发送至公司全体监事。会议由监事会主席于国庆先生主持，会议应到 监事 3 人，实到监事 3 人。本次会议的召集、召开程序及出席会议的监事人数符 合《公司法》和《公司章程》的规定。 经与会监事认真审议，本次会议以记名投票表决方式通过了以下决议： 一、审议通过了《2023 年半年度报告及其摘要》 经审核，监事会认为：董事会编制和审核公司《2023 年半年度报告及其摘 要》的程序符合法律、行政法规和中国证监会的规定，报告内容真实、准确、完 整地反映了公司的实际情况，不存在任何虚假记载、误导性陈述或重大遗漏。 表决结果：同意 3 票，反对 0 票，弃权 0 票。 经审核，监事会认为：公司《2023 年半年度募集资金存放与使用情况的专 项报告》符合中国证监会、深圳证券交易所关于上市公司募集资金存放和使用的 相关规定，严格按照公司《募集资金管理制度》的要求执行，如实的反映了公 ...

江苏长青农化股份有限公司 证券代码：002391 证券简称：长青股份 江苏长青农化股份有限公司投资者关系活动记录表 编号：2023-002 | --- | --- | |----------------|------------------------------------------------------------| | | √特定对象调研□分析师会议□媒体采访 | | 投资者关系活动 | □业绩说明会□新闻发布会□路演活动 | | 类别 | □现场参观□其他（请文字说明其他活动内容） | | | 光大证券-赵乃迪；国泰君安-钱伟伦；中邮证券-张泽亮；中信证 | | 参与单位名称 | 券-孙臣兴；开源证券-徐正凤；广发证券-牛璐；华安基金-张瑞； | | 及人员姓名 | 太平基金-夏文奇；浙商证券-陈海波；泓澄投资-陈骞；招商基金 | | | -于凡真；首创证券-甄理 | | 时间 | 2023.5.18 10:00-11:30 | 地点 公司会议室 接待人员姓名 财务总监兼董事会秘书：马长庆 证券事务代表：肖刚 1、今年公司预算收入 48 亿元，请问收入增长点主要来自哪 里？ 公司今年的业绩计划增长 ...

江苏长青农化股份有限公司 江苏长青农化股份有限公司 | | | 草胺原药项目、年产 1000 吨联苯菊酯原药项目的 | | --- | --- | --- | | | | 产能释放。（公司 2023 年度财务预算指标不代表 | | | | 公司对 2023 年度的盈利预测，能否实现取决于市 | | | | 场状况变化、经营团队的努力程度等多种因素， | | | | 存在很大的不确定性，请投资者特别注意。）感谢 | | | | 您的关注！ | | | 相比之下，长青的高分红政 | 尊敬的投资者您好：公司一贯注重通过分红特别 是现金分红与投资者共享公司成长，公司将继续 | | 6 | 策，是否能有持续性与稳定 | | | | 性。 | 按照《未来三年（2021 年—2023 年）股东回报规 | | | | 划》执行利润分配政策。感谢您对公司的关注！ | | | 农药板块中有一半公司的股价 | 尊敬的投资者您好：作为股东，当然希望公司股 | | | | 价恰当反映公司内在价值。但在实际市场环境 | | | 在这两年至少翻翻，而公司股 | 下，影响股价的因素很多，走势并不能单由谁说 | | 7 | 价还在上市 13 ...

关于举行 2022 年度业绩网上说明会的公告 股票代码：002391 股票简称：长青股份 公告编号：2023-010 江苏长青农化股份有限公司 2023 年 4 月 14 日 出席本次说明会的人员有：公司副董事长黄南章先生、总经理孙霞林先生、 财务总监兼董事会秘书马长庆先生、独立董事龚新海先生。 为广泛听取投资者的意见和建议，提升交流的针对性，公司现提前向投资者 公开征集问题，投资者可于 2023 年 4 月 20 日（星期四）15:00 前将关注的问题 通过电子邮件的形式发送至公司邮箱：irm@jscq.com（邮件请注明"业绩说明会" 字样），公司将在本次业绩说明会上对投资者普遍关注的问题重点进行回答，欢 迎广大投资者积极参与！ 特此公告。 江苏长青农化股份有限公司董事会 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有 虚假记载、误导性陈述或重大遗漏。 江苏长青农化股份有限公司（以下简称"公司"）《2022 年年度报告及摘要》 经公司第八届董事会第六次会议审议通过，并刊登在 2023 年 4 月 12 日的巨潮资 讯网（http://www.cninfo.com.cn）、《中国证券报》及《 ...

江苏长青农化股份有限公司 2023 年第一季度报告 证券代码：002391 证券简称：长青股份 公告编号：2023-004 江苏长青农化股份有限公司 2023 年第一季度报告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误导性陈述或重大遗漏。 重要内容提示： 1.董事会、监事会及董事、监事、高级管理人员保证季度报告的真实、准确、完整，不存在虚假记载、误导性陈述或重 大遗漏，并承担个别和连带的法律责任。 2.公司负责人、主管会计工作负责人及会计机构负责人(会计主管人员)声明：保证季度报告中财务信息的真实、准确、 完整。 3.第一季度报告是否经审计 □是 否 1 江苏长青农化股份有限公司 2023 年第一季度报告 一、主要财务数据 (一) 主要会计数据和财务指标 公司是否需追溯调整或重述以前年度会计数据 口是 | | 本报告期 | 上年同期 | 本报告期比上年同期增减 | | --- | --- | --- | --- | | | | | (%) | | 营业收入(元) | 1,021,723,217.16 | 913, 809, 250, 58 | 11.81% | | 归属于上市公 ...

Financial Performance - The company's operating revenue for 2022 was CNY 4,243,592,763.47, representing a 12.72% increase compared to CNY 3,764,717,682.44 in 2021[25]. - The net profit attributable to shareholders of the listed company was CNY 262,351,116.29, a 5.56% increase from CNY 248,534,907.87 in the previous year[25]. - The net cash flow from operating activities reached CNY 845,087,235.03, showing a significant increase of 97.13% from CNY 428,704,958.41 in 2021[25]. - The basic earnings per share for 2022 was CNY 0.4024, up 6.31% from CNY 0.3785 in 2021[25]. - Total assets at the end of 2022 amounted to CNY 7,473,984,440.34, an 8.87% increase from CNY 6,865,253,105.64 at the end of 2021[25]. - The company's total revenue for Q1 2022 was approximately ¥913.81 million, with Q2 at ¥1.22 billion, Q3 at ¥1.16 billion, and Q4 at ¥952.78 million[29]. - The net profit attributable to shareholders for Q1 2022 was approximately ¥80.05 million, Q2 was ¥121.69 million, Q3 was ¥99.40 million, and Q4 showed a loss of ¥38.79 million[29]. - The company reported a total of ¥8.41 million in non-recurring gains for 2022, compared to ¥7.48 million in 2021[31]. - The company's export sales amounted to 2,755.12 million yuan, marking a year-on-year increase of 32.92%[76]. - The total operating revenue for 2022 was ¥4,243,592,763.47, representing a year-on-year increase of 12.72% compared to ¥3,764,717,682.44 in 2021[79]. - The pesticide segment accounted for ¥4,169,233,271.86, or 98.25% of total revenue, with a year-on-year growth of 13.19%[80]. - Direct exports generated ¥2,148,888,778.39, which is 50.64% of total revenue, showing a significant increase of 49.08% from the previous year[80]. Research and Development - The company has increased its R&D investment to enhance its independent innovation system, focusing on developing green production processes and key technologies[38]. - Research and development expenses increased by 34.76% to ¥202,575,782.32 in 2022, driven by higher investment in new technologies[89]. - The total amount of research and development investment reached ¥217,918,178.14, representing 5.14% of total revenue, up from 4.11% in 2021[90]. - The number of research and development personnel increased by 4.88% to 344 in 2022, although the proportion of R&D staff to total employees decreased to 14.61%[90]. - The company is focused on transitioning to high-end product manufacturing and increasing the technological content of its pesticide products[114]. - The company plans to focus on the research and development of high-efficiency, low-toxicity, and low-residue pesticides[116]. Market Position and Strategy - The company is positioned to benefit from the ongoing consolidation in the pesticide industry, focusing on large-scale and intensive operations[37]. - The company has established a comprehensive sales network covering all 30 provinces in China, enhancing its domestic sales capabilities[52]. - The company utilizes a dual export strategy, including self-operated exports and indirect exports through domestic traders, maintaining stable relationships with overseas clients[52]. - The company has developed over 30 active ingredients and more than 130 formulations, with significant sales in both domestic and international markets, including a cumulative promotion area of over 300 million mu for new products[38]. - The company has established a strong marketing network, covering over 30 provinces and regions in China, and has established stable partnerships with multinational companies[70]. - The company plans to enhance its product structure and provide comprehensive technical service solutions for crops, targeting the domestic formulation market[115]. - The company aims to expand its market presence in Southeast Asia, targeting a 25% increase in market share by 2025[137]. Environmental Management - The company has established a comprehensive environmental management system, achieving ISO 14001 certification[67]. - The company is committed to environmental protection, with waste emissions meeting national standards, but increased operational costs for environmental facilities may affect profitability[120]. - The company has implemented measures to ensure compliance with various environmental discharge standards, including GB 8978-1996 and GB 16297-1996[177]. - The company has installed online monitoring devices for wastewater and air pollutants, ensuring real-time data compliance with national emission standards[184]. - The company has been recognized as a "Green Factory" by the China Petroleum and Chemical Industry Federation, highlighting its commitment to environmental protection[190]. - The company has invested 8 million yuan in environmental governance projects, primarily for upgrading environmental protection facilities[185]. Governance and Compliance - The company has a governance structure that includes a board of directors with independent members, ensuring effective decision-making and risk management[126]. - The company maintains operational independence from its controlling shareholder, with a complete procurement, production, and sales system[128]. - The company has established an independent financial department with dedicated personnel and a complete financial accounting system, ensuring compliance with accounting standards[129]. - The company has implemented a stock buyback program, with several executives reducing their holdings as part of this initiative[132]. - The company has received a standard unqualified opinion from the auditing agency for the annual financial report[196]. - The company has not faced any administrative penalties related to environmental issues during the reporting period[186]. Production and Capacity - The production capacity utilization rate for the main product "Active Ingredient" is 90.36% with a designed capacity of 25,960 tons/year[54]. - The production capacity utilization rate for the main product "Formulation" is 85.10% with a designed capacity of 14,500 tons/year[54]. - The company has a total of 13,000 tons of "Active Ingredient" capacity under construction[54]. - The company’s production process is governed by strict procedural regulations to ensure quality and efficiency, with ongoing monitoring of key production parameters[50]. - The company has successfully launched several production projects, including a 10,000-ton 2-methyl-6-ethyl aniline project and a 2,000-ton Kungfu chrysanthemum ester project, contributing to its production capacity[187]. Future Outlook - The company projects a revenue target of CNY 4.8 billion for 2023, representing a 13.11% increase compared to 2022[116]. - The company has set a performance guidance of 1.5 billion yuan in revenue for 2023, reflecting a growth target of 25%[137]. - The management emphasized a focus on improving operational efficiency, aiming for a 5% reduction in production costs[137]. - The company plans to increase funding through bank loans and capital markets to support ongoing projects and ensure sustainable development in 2023[119].

江苏长青农化股份有限公司 证券代码：002391 证券简称：长青股份 编号：2015-001 | --- | --- | --- | |-----------------------|----------------------------------|----------------------------------------------------------| | | | | | 投资者关系活动 | √ | 特定对象调研 □分析师会议 □媒体采访 | | 类别 | □ | 业绩说明会 □新闻发布会 □路演活动 | | | | □现场参观 □其他 （请文字说明其他活动内容） | | | 南方基金：张磊； | | | | 中欧基金：丁星乐； | | | 参与单位名称及 | 平安资产：孙惠成 | | | 人员姓名 | 泰康资产：张烁； | | | | 太平洋保险：张晓烽； | | | | | | | | 九泰基金：于庭泽 2015.8.27 13:30 | | | 时间 | | | | 地点 | 上海紫金山大酒店 | | | 上市公司接待人 员姓名 | 闵 丹 | | | 投资者关系活动 | 1 | 、公 ...

江苏长青农化股份有限公司 证券代码：002391 证券简称：长青股份 编号：2015-002 | --- | --- | --- | |-----------------------|-------------------------|------------------------------------------------------------| | | | | | 投资者关系活动 | √ | 特定对象调研 □分析师会议 □媒体采访 | | 类别 | □ | 业绩说明会 □新闻发布会 □路演活动 | | | | □现场参观 □其他 （请文字说明其他活动内容） | | 参与单位名称及 | 国联安基金 : | 周南 | | 人员姓名 | 摩根士丹利华鑫基金:朱睿 | | | 时间 | 2015.9.9 9:45 | | | 地点 | | 无锡灵山元—希尔顿逸林酒店 | | 上市公司接待人 员姓名 | 闵 丹、马长庆 | | | 投资者关系活动 | | 1、公司麦草畏产品生产及销售情况如何？ | | 主要内容介绍 | 2015 | 年，南通子公司麦草畏原药项目产能得到进一步提 | | | | 升，市场需求 ...